SHARMILA ANANDASABAPATHY to Risk Assessment
This is a "connection" page, showing publications SHARMILA ANANDASABAPATHY has written about Risk Assessment.
Connection Strength
0.092
-
Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer. 2007 Feb 15; 109(4):668-74.
Score: 0.036
-
Innovative drug treatments for viral and autoimmune myocarditis. Heart Dis. 2002 May-Jun; 4(3):171-83.
Score: 0.026
-
Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study. J Acquir Immune Defic Syndr. 2019 07 01; 81(3):e65-e72.
Score: 0.021
-
Molecular mechanisms in Barrett's metaplasia and its progression. Semin Oncol. 2007 Apr; 34(2 Suppl 1):S2-6.
Score: 0.009